COLACI, Michele
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 19.388
EU - Europa 11.932
AS - Asia 6.690
SA - Sud America 916
AF - Africa 161
OC - Oceania 18
Continente sconosciuto - Info sul continente non disponibili 10
Totale 39.115
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 19.110
IT - Italia 5.444
GB - Regno Unito 2.928
SG - Singapore 2.053
CN - Cina 1.705
SE - Svezia 802
HK - Hong Kong 796
BR - Brasile 705
VN - Vietnam 617
DE - Germania 545
FR - Francia 476
UA - Ucraina 445
FI - Finlandia 426
TR - Turchia 357
BD - Bangladesh 349
RU - Federazione Russa 290
NL - Olanda 152
IN - India 146
BG - Bulgaria 138
KR - Corea 134
CA - Canada 133
ID - Indonesia 115
MX - Messico 85
AR - Argentina 82
JP - Giappone 67
AE - Emirati Arabi Uniti 63
ZA - Sudafrica 56
IQ - Iraq 53
PL - Polonia 38
PK - Pakistan 34
EC - Ecuador 32
ES - Italia 28
BE - Belgio 27
IE - Irlanda 27
MY - Malesia 26
MA - Marocco 24
RO - Romania 24
CH - Svizzera 23
CO - Colombia 22
VE - Venezuela 22
CL - Cile 20
SA - Arabia Saudita 19
IR - Iran 18
TN - Tunisia 18
AU - Australia 17
EG - Egitto 17
AT - Austria 15
BZ - Belize 15
LT - Lituania 15
PH - Filippine 15
NP - Nepal 14
UZ - Uzbekistan 14
KE - Kenya 12
TH - Thailandia 11
AZ - Azerbaigian 10
HU - Ungheria 10
JO - Giordania 10
PY - Paraguay 10
BO - Bolivia 9
PE - Perù 9
CZ - Repubblica Ceca 8
GR - Grecia 8
IL - Israele 8
NO - Norvegia 8
TW - Taiwan 8
BY - Bielorussia 7
EU - Europa 7
KG - Kirghizistan 7
DO - Repubblica Dominicana 6
HN - Honduras 6
LB - Libano 6
PT - Portogallo 6
ET - Etiopia 5
GE - Georgia 5
GT - Guatemala 5
HR - Croazia 5
KZ - Kazakistan 5
MD - Moldavia 5
OM - Oman 5
RS - Serbia 5
SV - El Salvador 5
AL - Albania 4
CR - Costa Rica 4
CY - Cipro 4
DZ - Algeria 4
JM - Giamaica 4
ML - Mali 4
PA - Panama 4
SK - Slovacchia (Repubblica Slovacca) 4
SN - Senegal 4
UY - Uruguay 4
BA - Bosnia-Erzegovina 3
BH - Bahrain 3
DK - Danimarca 3
LU - Lussemburgo 3
PS - Palestinian Territory 3
QA - Qatar 3
SI - Slovenia 3
TT - Trinidad e Tobago 3
A2 - ???statistics.table.value.countryCode.A2??? 2
Totale 39.073
Salva come PNG Salva come JPEG
Città #
Southend 2.236
Fairfield 1.826
Santa Clara 1.618
Ashburn 1.509
Singapore 1.381
Woodbridge 1.068
Houston 842
Hong Kong 784
Chandler 751
Chicago 738
Jacksonville 725
Seattle 688
Wilmington 621
Cambridge 599
San Jose 535
Ann Arbor 532
Los Angeles 518
Dearborn 502
Nyköping 425
Milan 406
Rome 381
Hefei 369
Beijing 351
London 343
Council Bluffs 323
Salt Lake City 308
Helsinki 306
New York 244
Izmir 221
The Dalles 218
Modena 213
Ho Chi Minh City 181
Hanoi 162
Tampa 162
San Diego 148
Princeton 139
Sofia 134
Elk Grove Village 131
Dallas 129
Seoul 127
Eugene 123
Lauterbourg 110
Naples 105
Buffalo 99
Florence 95
Bologna 93
Palermo 89
Jakarta 82
Sterling 78
Shanghai 77
Frankfurt am Main 75
Catania 74
Turin 74
Bremen 73
Redwood City 72
Bari 71
Des Moines 69
Moscow 67
São Paulo 63
Genoa 59
Columbus 58
Lancaster 54
Atlanta 51
Verona 46
Phoenix 45
Detroit 44
Guangzhou 44
Miami 44
Padova 41
Toronto 41
Dulles 38
Orem 38
Tokyo 37
Boardman 36
Mexico City 34
Cagliari 32
Norwalk 31
Da Nang 30
Munich 30
Denver 27
Kunming 27
Falls Church 26
Haiphong 26
Johannesburg 24
Warsaw 24
Amsterdam 23
Chennai 23
Parma 23
Pisa 23
Salerno 23
Delhi 22
Dublin 22
Jersey City 22
Pittsburgh 22
San Francisco 22
Brooklyn 21
Baghdad 20
Belo Horizonte 20
Brescia 20
Dong Ket 20
Totale 25.796
Salva come PNG Salva come JPEG
Nome #
INTERSTIZIOPATIA POLMONARE NON CLASSIFICABILE O SECONDARIA A CONNETTIVITE INDIFFERENZIATA. IMPORTANZA E DIFFICOLTÀ DI UNA DIAGNOSI DIFFERENZIALE. 3.855
ALTERAZIONI CAPILLAROSCOPICHE IN CORSO DI DERMATOMIOSITE E SCLEROSI SISTEMICA; VERSO L’INDIVIDUAZIONE DI PATTERN SPECIFICI 957
Thyroid Involvement in Hepatitis C Virus-Infected Patients with/without Mixed Cryoglobulinemia 761
Semeiotica dell'articolazione temporo-mandibolare 559
Capillaroscopic skin ulcer risk index: a new prognostic tool for digital skin ulcer development in systemic sclerosis patients. 482
Evoluzione dello CSURI (Capillaroscopic Skin Ulcer Risk Index) in pazienti affetti da sclerosi sistemica in terapia con antiendotelina-1 e prostanoidi 455
Oxycodone in the Long-Term Treatment of Chronic Pain Related to Scleroderma Skin Ulcers. 449
Bronchoalveolar lavage and response to cyclophosphamide in scleroderma alveolitis. 440
Nailfold Videocapillaroscopy Alterations in Dermatomyositis and Systemic Sclerosis: Toward Identification of a Specific Pattern 388
Endocrine manifestations of hepatitis C virus infection. 384
Systemic sclerosis and cryoglobulinemia: our experience with overlapping syndrome of scleroderma and severe cryoglobulinemic vasculitis and review of the literature. 384
Thymus alterations and systemic sclerosis 383
Heart involvement and systemic sclerosis 377
D-penicillamine in the treatment of eosinophilic fasciitis: case reports and review of the literature. 373
Radiological thymus alterations in systemic sclerosis: our experience and a review of the literature. 372
Breast cancer in systemic sclerosis: Results of a cross-linkage of an Italian Rheumatologic Center and a population-based Cancer Registry and review of the literature 372
CXCL10 (α) and CCL2 (β) chemokines in systemic sclerosis - A longitudinal study 367
Incidence of thyroid disorders in systemic sclerosis: results from a longitudinal follow-up. 366
Systemic sclerosis evolution of disease pathomorphosis and survival. Our experience on Italian patients' population and review of the literature 356
Current treatment of hepatitis C-associated rheumatic diseases. 355
Chemokines in the pathogenesis and as therapeutical markers and targets of HCV chronic infection, and HCV extrahepatic manifestations 354
Carotidynia Possibly due to Localized Vasculitis in a Patient with Latent Mycobacterium tuberculosis Infection. 346
Scleroderma digital ulcers complicated by infection with fecal pathogens. 345
Established coronary artery disease in systemic sclerosis compared to type 2 diabetic female patients: a cross-sectional study 345
Aortic pulse wave velocity measurement in systemic sclerosis patients. 342
Elevated Troponin Serum Levels in Adult Onset Still's Disease 341
IFN-γ and TNF-α induce a different modulation of interleukin-6 in systemic sclerosis fibroblasts compared to healthy controls. 339
Adult-onset Still’s disease: an Italian multicentre retrospective observational study of manifestations and treatments in 245 patients 336
Cardio-pulmonary disease management in patients with systemic sclerosis: cardio-rheumatology clinic and patient care standardisation proposal 329
High levels of circulating N-terminal pro-brain natriuretic peptide in patients with hepatitis C. 325
Recombinant human erythropoietin stimulates vasculogenesis and wound healing in a patient with systemic sclerosis complicated by severe skin ulcers. 325
Treatment of severe scleroderma skin ulcers with recombinant human erythropoietin 324
Serum 25-OH vitamin D levels in systemic sclerosis: analysis of 140 patients and review of the literature 323
Staphylococcus protein A-based extracorporeal immunoadsorption and thalidomide in the treatment of skin manifestation of dermatomyositis: a case report. 322
Efficacia di terapia con immunoassorbimento con proteina A dello stafilococco e talidomide in un caso di dermatomiosite refrattaria. 322
Associations between Systemic Sclerosis and Thyroid Diseases 322
L-Arginine in pregnant scleroderma patients 322
Antiendothelial cell antibodies induce apoptosis of bone marrow endothelial progenitors in systemic sclerosis 320
Gynaecological Screening for Cervical and Vulvar Malignancies in a Cohort of Systemic Sclerosis Patients: Our Experience and Review of the Literature 318
High interleukin-6 and tumor necrosis factor-alpha serum levels in hepatitis C infection associated or not with mixed cryoglobulinemia 309
Lung cancer in scleroderma: results from an Italian rheumatologic center and review of the literature. 309
Platelet gel in the treatment of severe scleroderma skin ulcers. 308
CORRELATION OF A QUANTITATIVE VIDEOCAPILLAROSCOPIC SCORE WITH THE DEVELOPMENT OF DIGITAL SKIN ULCERS IN SCLERODERMA PATIENTS 307
Nailfold capillaroscopic changes in dermatomyositis and polymyositis 304
Long-term treatment with rituximab in interstitial lung disease related to systemic sclerosis: our clinical experience 303
Predictive value of isolated DLCO reduction in systemic sclerosis patients without cardio-pulmonary involvement at baseline 301
Immunopathogenesis of HCV-related endocrine manifestations in chronic hepatitis and mixed cryoglobulinemia 296
Haematological Malignancies in Systemic Sclerosis Patients: Case Reports and Review of the World Literature 286
Cardiovascular risk and prostanoids in systemic sclerosis 285
Prevalence and evolution of scleroderma pattern at nailfold videocapillaroscopy in systemic sclerosis patients: Clinical and prognostic implications 282
Interstitial pneumonia with autoimmune features and undifferentiated connective tissue disease: Our interdisciplinary rheumatology-pneumology experience, and review of the literature 282
Polymyositis following Pandemic Influenza A (H1N1) and 2009-10 Seasonal Trivalent Vaccines 281
Management of cardiopulmonary disease in patients with systemic sclerosis: cardiorheumatology clinic and patient care standardization proposal 280
Micro and nanoparticles as possible pathogenetic co-factors in mixed cryoglobulinemia 279
Induction of CXCL10 secretion by interferon-γ and tumour necrosis factor-α and its inhibition by peroxisome proliferator-activated receptor-γ agonists in cultured scleroderma fibroblasts. 277
High circulating chemokines (C-X-C motif) ligand 9, and (C-X-C motif) ligand 11, in hepatitis C-associated cryoglobulinemia. 276
Prediction risk chart for scleroderma digital ulcers: A composite predictive model based on capillaroscopic, demographic and clinico-serological parameters 274
CAPILLAROSCOPIC SKIN ULCER RISK INDEX (CSURI) IN SYSTEMIC SCLEROSIS: RESULTS FROM AN ITALIAN MULTICENTER VALIDATION STUDY 273
Predictive role of capillaroscopic skin ulcer risk index in systematic sclerosis: a multicentre validation study 273
Correlation of a quantitative videocapillaroscopic score with the development of digital skin ulcers in scleroderma patients 273
UNCLASSIFIABLE INTERSTITIAL LUNG DISEASE OR UNDIFFERENTIATED CONNECTIVE TISSUE DISEASE? A CHALLENGING DIFFERENTIAL DIAGNOSIS 270
Endocrine Manifestations of HCV-Positive Cryoglobulinemia 269
Advanced oxidation protein products in serum of patients with systemic sclerosis: a possible indicator of clinical evolution 268
New targeted molecular therapies for dedifferentiated thyroid cancer 267
Renal Manifestations of Hepatitis C Virus 263
[CXCR3 and CXCL10 in autoimmune thyroiditis] 262
The Expanding Spectrum of Clinical Features in HCV-Related Mixed Cryoglobulinemia 260
The safety of iloprost in systemic sclerosis in a real-life experience 258
Hepatitis C virus syndrome: A constellation of organ- and non-organ specific autoimmune disorders, B-cell non-Hodgkin's lymphoma, and cancer 257
Use of Neem oil and Hypericum perforatum for treatment of calcinosis-related skin ulcers in systemic sclerosis 257
Treatment of HCV-related mixed cryoglobulinemia 255
HCV-related rheumatic manifestations and therapeutic strategies 254
Rituximab in the treatment of patients with systemic sclerosis. Our experience and review of the literature 254
Novel Therapies for Thyroid Autoimmune Diseases 253
IP-10 in autoimmune thyroiditis 252
Scleroderma Digital Ulcers Complicated by Infection with Fecal Pathogens. 252
Validation study of predictive value of capillaroscopic skin ulcer risk index (CSURI) in scleroderma patients treated with bosentan 248
RHEUMATOID ARTHRITIS RELATED INTERSTITIAL LUNG DISEASE. RADIOLOGICAL PATTERNS AND CORRELATIONS WITH CLINICAL, SEROLOGICAL AND DEMOGRAPHIC FEATURES OF DISEASE 247
Epstein-barr virus reactivation after infliximab in rheumatoid arthritis: a case report. 242
The treatment of skin ulcers in systemic sclerosis: use of granulocyte-colony stimulating factor (G-CSF) in 26 patients 241
RET TKI: potential role in thyroid cancers. 241
Osteomyelitis complicating scleroderma digital ulcers. 241
Neurologic Complications Associated with Sjögren's Disease: Case Reports and Modern Pathogenic Dilemma 236
Scleroderma skin ulcers definition, classification and treatment strategies our experience and review of the literature 235
ADULT ONSET STILL'S DISEASE: A MULTICENTER RETROSPECTIVE COHORT STUDY OF 233 ITALIAN PATIENTS 230
CXCL10 in psoriasis 229
PAP-TEST FEATURES IN A COHORT OF SYSTEMIC SCLEROSIS PATIENTS 227
Systematic review of 2008-2012 literature and update of recommendations for the use of methotrexate in rheumatic diseases, with a focus on rheumatoid arthritis. 224
Severe alopecia complicating systemic sclerosis 222
Mixed cryoglobulinemia syndrome: where are we going to? 216
PATIENTS WITH MIXED CRYOGLOBULINEMIA AND HCV INFECTION, IN PRESENCE OR ABSENCE OF AUTOIMMUNE THYROIDITIS, HAVE HIGH SERUM LEVELS OF (CXC MOTIF) LIGAND (CXCL)9 AND CXCL11 CHEMOKINES 215
Incidence of thyroid disorders in mixed cryoglobulinemia: Results from a longitudinal follow-up 213
Tocilizumab for the treatment of patients with rheumatoid arthritis and interstitial lung diseases: a case series 209
Th1 and Th2 chemokine serum levels in systemic sclerosis in the presence or absence of autoimmune thyroiditis. 209
High serum levels of silica nanoparticles in systemic sclerosis patients with occupational exposure: Possible pathogenetic role in disease phenotypes 205
Trattamento della fascite eosinofila con D-penicillamina: descrizione di 3 casi. 203
Serum a-Chemokine CXCL10 and b-Chemokine CCL2 Levels in HCV-Positive Cryoglobulinemia 203
Lung and Breast Cancer in Systemic Sclerosis: Correlations with the Disease's Features 196
Increased CXCL9 serum levels in hepatitis C-related mixed cryoglobulinemia, with autoimmune thyroiditis, associated with high levels of CXCL10. 196
Predictive Value of DLCO Reduction in Scleroderma Patients Without Cardio-Pulmonary Involvement at Baseline 196
Totale 34.268
Salva come PNG Salva come JPEG
Categoria #
all - tutte 147.996
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 147.996
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021225 0 0 0 0 0 0 0 0 0 0 0 225
2021/20222.636 114 259 280 204 100 181 140 135 280 223 390 330
2022/20233.426 395 246 182 231 401 421 209 307 426 133 299 176
2023/20243.048 134 196 196 345 503 260 290 308 88 185 236 307
2024/20256.012 290 120 152 487 1.193 891 405 320 624 321 601 608
2025/202611.527 490 303 670 1.711 2.855 742 1.187 460 874 830 746 659
Totale 39.401